Wednesday, November 20, 2024
HomeNews

News

FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes

The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an...

Idorsia U.S. Announces First Wave of Patients Prescribed QUVIVIQ (daridorexant) through Partnership with Pharmacy Services Provider

Following the launch of QUVIVIQ™ (daridorexant) CIV on May 2, Idorsia Pharmaceuticals, U.S. Inc. announced that the first wave of patients has been prescribed...

Diadem Announces Publication of Clinical Study Confirming Its AlzoSure Predict Blood Test Can Accurately Predict Progression to Alzheimer’s Disease Six Years Before Diagnosis

Diadem SpA announced publication of the results of a clinical validation study of its AlzoSure Predict prognostic blood test for Alzheimer's disease (AD). The...

A Breakthrough in Biopharmaceutical Protein Production; Leniobio Announces a New Proprietary Cell Line Devoid of Plant Glycans

German life science biotech firm, LenioBio GmbH, announced the generation of a novel plant glycan knockout cell line that will increase the versatility and...

Tethis Launches See.d, the First Fully Automated, Standardized Pre-analytical Platform for Comprehensive Liquid Biopsy Testing

Tethis S.p.A announces the release of See.d, the first universal blood sample preparator for liquid biopsy analysis. This innovative technology performs a completely automated...
0FansLike
0FollowersFollow
spot_img

Hot Topics